Ste Tunisienne Des Industries Pharmaceutique SA (SIPHA)

Tunis

Currency in TND

3.45

0.00(0.00%)

Closed·05/02

Fair Value

Unlock Value

Day's Range

3.45

52 wk Range

3.40

6.68

SIPHA Income Statement

Featured here, the Income Statement (earnings report) for Ste Tunisienne Des Industries Pharmaceutique SA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2010

31/12

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

Total Revenues

aa.aa

44.79

42.58

37.3

33.19

24.4

Total Revenues Growth

aa.aa

+8.82%

-4.93%

-12.41%

-11%

-26.47%

Cost Of Revenues

aa.aa

20.95

20.09

20.11

21.08

15.38

Gross Profit

aa.aa

23.84

22.48

17.19

12.11

9.03

Gross Profit Growth

aa.aa

+10.81%

-5.67%

-23.56%

-29.54%

-25.45%

Gross Profit Margin %

aa.aa

53.22%

52.81%

46.08%

36.48%

36.99%

Other Operating Expenses, Total

aa.aa

24.99

24.43

22.53

22.15

22.68

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.84%	-2.27%	-7.78%	-1.66%	+2.38%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	19.74	19.53	18.48	18.29	18.42
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.67	2.59	1.93	1.93	2.74

Operating Income

aa.aa

-1.16

-1.94

-5.34

-10.04

-13.65

Operating Income Growth

aa.aa

+72.55%

-67.83%

-175.06%

-88.06%

-35.94%

EBIT Margin %

aa.aa

-2.58%

-4.56%

-14.32%

-30.26%

-55.94%

Net Interest Expenses

aa.aa

-0.87

-0.72

-0.98

-1.29

-1.7

Net Interest Expenses Growth

aa.aa

-353.25%

+17.07%

-36.1%

-31.97%

-31.22%

Interest Expense, Total

aa.aa

-0.96

-0.74

-1.01

-1.34

-1.81

Interest And Investment Income

aa.aa

0.09

0.02

0.03

0.05

0.12

Other Non Operating Expenses, Total

aa.aa

-0.35

-1.37

-1.22

-2.91

0.88

EBT, Excl. Unusual Items

aa.aa

-2.37

-4.03

-7.54

-14.25

-14.47

Gain (Loss) On Sale Of Assets

aa.aa

0.05

0.36

0.06

Other Unusual Items, Total

aa.aa

-0.01

-0

EBT, Incl. Unusual Items

aa.aa

-2.75

-3.68

-7.66

-14.2

-14.47

EBT, Incl. Unusual Items Growth

aa.aa

+62.43%

-33.55%

-108.15%

-85.43%

-1.95%

EBT, Incl. Unusual Items Margin

aa.aa

-6.15%

-8.64%

-20.53%

-42.77%

-59.3%

Income Tax Expense

aa.aa

0.09

0.08

0.07

0.05

Net Income to Company

aa.aa

-2.85

-3.77

-7.73

-14.27

-14.52

Minority Interest

aa.aa

Net Income

aa.aa

-2.85

-3.77

-7.73

-14.27

-14.52

Net Income Growth

aa.aa

+61.62%

-32.45%

-105.21%

-84.44%

-1.81%

Net Income Margin %

aa.aa

-6.35%

-8.85%

-20.74%

-42.98%

-59.52%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-2.85

-3.77

-7.73

-14.27

-14.52

Basic EPS - Continuing Operations

aa.aa

-2.09

-4.3

-7.93

-8.07

Basic EPS - Continuing Operations Growth

aa.aa

-105.21%

-84.44%

-1.81%

Diluted EPS - Continuing Operations

aa.aa

-2.09

-4.3

-7.93

-8.07

Diluted EPS - Continuing Operations Growth

aa.aa

-105.21%

-84.44%

-1.81%

Basic Weighted Average Shares Outstanding

aa.aa

1.8

Diluted Weighted Average Shares Outstanding

aa.aa

1.8

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

1.43

0.37

-3.22

-8.11

-12.13

EBITDA Growth

aa.aa

+191.47%

-74.27%

-977.97%

-151.74%

-49.55%

EBITDA Margin %

aa.aa

3.18%

0.86%

-8.64%

-24.43%

-49.7%

EBIT

aa.aa

-1.16

-1.94

-5.34

-10.04

-13.65

* In Millions of TND (except for per share items)

FAQ

What was Ste Tunisienne Des Industries Pharmaceutique’s revenue at year end?

At the end of the last reported fiscal year, Ste Tunisienne Des Industries Pharmaceutique (SIPHA) recorded total revenue of 24.40.

How much revenue did Ste Tunisienne Des Industries Pharmaceutique report in the most recent quarter?

In its most recent quarterly earnings report, Ste Tunisienne Des Industries Pharmaceutique posted revenue of 9.29.

What was Ste Tunisienne Des Industries Pharmaceutique’s net income for the year?

For the full year, Ste Tunisienne Des Industries Pharmaceutique reported net income of -14.52.

How much net income did Ste Tunisienne Des Industries Pharmaceutique post in the last quarter?

In the most recent quarter, Ste Tunisienne Des Industries Pharmaceutique (SIPHA) posted net income of -9.75.

What was Ste Tunisienne Des Industries Pharmaceutique’s gross profit for the year?

Gross profit for the year was reported at 9.03.

How much gross profit did Ste Tunisienne Des Industries Pharmaceutique generate last quarter?

Ste Tunisienne Des Industries Pharmaceutique recorded gross profit of 4.53 in its latest quarterly report.

What was Ste Tunisienne Des Industries Pharmaceutique’s annual operating income?

For the full year, Ste Tunisienne Des Industries Pharmaceutique (SIPHA) reported operating income of -13.65.

What was Ste Tunisienne Des Industries Pharmaceutique’s operating income last quarter?

Quarterly operating income was -6.86.

What was Ste Tunisienne Des Industries Pharmaceutique’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -6.25.

What was the quarter-over-quarter change in EBITDA for Ste Tunisienne Des Industries Pharmaceutique?

EBITDA changed by -6.91% compared to the last quarter.

How did Ste Tunisienne Des Industries Pharmaceutique’s revenue change compared to the previous quarter?

Revenue changed by -31.04% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Ste Tunisienne Des Industries Pharmaceutique?

In the latest quarter 2026, gross profit changed by 3.81% from the previous quarter.

S&P/TSX

32,470.98

+476.38

+1.49%

S&P/TSX 60

1,882.66

+22.09

+1.19%

US 30

50,116.20

+1,207.8

+2.47%

US 500

6,924.30

+126.2

+1.86%

S&P 500 VIX

17.76

-4.01

-18.42%

DAX

24,721.46

+230.40

+0.94%

Dollar Index

97.51

-0.190

-0.19%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	22.83	-10.12%	19.62M
Enbridge	68.74	-0.58%	12.76M
Toronto Dominion Bank	131.99	+1.40%	8.24M
Canadian Natural	53.40	+2.89%	7.94M
Bank of Nova Scotia	104.30	+1.07%	3.99M
Bank of Montreal	193.48	+0.98%	2.70M
RBC	232.72	+0.69%	2.65M

Name	Last	Chg. %	Vol.
Grounded People Apparel	0.100	+1,900.00%	2.50K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Verses AI	2.60	+188.89%	109.79K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Martello Tech	0.0100	+100.00%	17.31K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Planet Based Foods Global	0.01	-81.82%	35.00K
TripSitter Clinic	0.15	-69.39%	1.50K
Kovo Healthtech	0.02	-66.67%	240.01K
Global Cannabis Apps	0.010	-50.00%	220.00K
MyndTec	0.01	-50.00%	25.00K
Waverley Pharma	0.0150	-50.00%	12.01K

Trending Stocks

Name	Last	Chg. %	Vol.
ARC Resources	22.83	-10.12%	19.62M
Constellation Software	2,434.02	-1.74%	112.00K
Hut 8	72.430	+18.99%	1.74M
Air Canada	21.16	+1.58%	2.39M
Bitfarms	2.92	+25.32%	9.92M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaa	88.99	+63.73%	145.70
Aaaaa Aaaaaaaaa	8.03	+53.43%	12.32
Aaaaa A	21.38	+49.41%	31.94
Aaaaaa Aa A A	61.53	+49.38%	91.91
Aaaaaaa Aaaaaaaaaaa	112.92	+42.02%	160.37
Aaaaa Aa Aaaa	2,434.02	+40.00%	3,407.63
Aaaaaaaaaaaa Aaaa	91.25	+38.99%	126.83

Name	Last	Upside	Fair Value
Aa Aaaaa	88.99	+63.73%	145.70
Aaaaa Aaaaaaaaa	8.03	+53.43%	12.32
Aaaaa A	21.38	+49.41%	31.94
Aaaaaa Aa A A	61.53	+49.38%	91.91
Aaaaaaa Aaaaaaaaaaa	112.92	+42.02%	160.37
Aaaaa Aa Aaaa	2,434.02	+40.00%	3,407.63
Aaaaaaaaaaaa Aaaa	91.25	+38.99%	126.83

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Ste Tunisienne Des Industries Pharmaceutique SA (SIPHA)

SIPHA Income Statement

FAQ

What was Ste Tunisienne Des Industries Pharmaceutique’s revenue at year end?

How much revenue did Ste Tunisienne Des Industries Pharmaceutique report in the most recent quarter?

What was Ste Tunisienne Des Industries Pharmaceutique’s net income for the year?

How much net income did Ste Tunisienne Des Industries Pharmaceutique post in the last quarter?

What was Ste Tunisienne Des Industries Pharmaceutique’s gross profit for the year?

How much gross profit did Ste Tunisienne Des Industries Pharmaceutique generate last quarter?

What was Ste Tunisienne Des Industries Pharmaceutique’s annual operating income?

What was Ste Tunisienne Des Industries Pharmaceutique’s operating income last quarter?

What was Ste Tunisienne Des Industries Pharmaceutique’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Ste Tunisienne Des Industries Pharmaceutique?

How did Ste Tunisienne Des Industries Pharmaceutique’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Ste Tunisienne Des Industries Pharmaceutique?

Trending Stocks